カテゴリ： MarketLine, アメリカ, 企業調査

Progenics Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4527
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：51
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Progenics Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Progenics Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Progenics Pharmaceuticals, Inc. (Progenics or ‘the company’) is a biopharmaceutical company focused on the development of innovative medicines and other technologies for targeting and treating cancer. Its product portfolio includes therapeutic agents such as AZERDA and PSMA TTC that are designed to precisely target cancer and prostate-specific membrane antigen (“PSMA”) targeted imaging agents including PyL used to treat prostate cancer. In addition, it also enters into licensing agreements with the University of Zurich and the Paul Scherrer, The University of Western Ontario, Johns Hopkins University and with Bayers subsidiary for acquiring worldwide sublicensable rights to enhance their product candidates. The company is headquartered in New York, the US.

Scope

- Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Progenics Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Progenics Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Progenics Pharmaceuticals, Inc.: Company Overview
Progenics Pharmaceuticals, Inc.: Overview and Key Facts
Progenics Pharmaceuticals, Inc.: Overview
Progenics Pharmaceuticals, Inc.: Key Facts
Progenics Pharmaceuticals, Inc.: Key Employees
Progenics Pharmaceuticals, Inc.: Key Employee Biographies
Progenics Pharmaceuticals, Inc.: Major Products and Services
Progenics Pharmaceuticals, Inc.: Company History
Progenics Pharmaceuticals, Inc.: Management Statement
Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
Progenics Pharmaceuticals, Inc.: Key Competitors
Progenics Pharmaceuticals, Inc.: Company Analysis
Progenics Pharmaceuticals, Inc.: Business Description
Progenics Pharmaceuticals, Inc.: SWOT Analysis
Progenics Pharmaceuticals, Inc.: SWOT Overview
Progenics Pharmaceuticals, Inc.: Strengths
Progenics Pharmaceuticals, Inc.: Weaknesses
Progenics Pharmaceuticals, Inc.: Opportunities
Progenics Pharmaceuticals, Inc.: Threats
Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Progenics Pharmaceuticals, Inc.: Financial Deals Overview
Progenics Pharmaceuticals, Inc.: Targets and Partners
Progenics Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Progenics Pharmaceuticals, Inc.: Advisors
Progenics Pharmaceuticals, Inc.: Top Legal Advisors
Progenics Pharmaceuticals, Inc.: Top Financial Advisors
Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions
Progenics Pharmaceuticals, Inc.: Capital Raising
Progenics Pharmaceuticals, Inc.: Partnership
Progenics Pharmaceuticals, Inc.: Private Equity and Ownership
Progenics Pharmaceuticals, Inc.: Recent Developments
Progenics Pharmaceuticals, Inc.: News and Events Summary
Progenics Pharmaceuticals, Inc.: Corporate Governance
Progenics Pharmaceuticals, Inc.: Financial Performance
Progenics Pharmaceuticals, Inc.: Market Developments
Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
Progenics Pharmaceuticals, Inc.: Research & Development
Progenics Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Progenics Pharmaceuticals, Inc.: Key Facts
Table 2: Progenics Pharmaceuticals, Inc.: Key Employees
Table 3: Progenics Pharmaceuticals, Inc.: Company History
Table 4: Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Progenics Pharmaceuticals, Inc.: Key Competitors
Table 6: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Progenics Pharmaceuticals, Inc.: Targets and Partners
Table 10: Progenics Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 11: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 19: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 20: Progenics Pharmaceuticals, Inc.: News and Events Summary
Table 21: Progenics Pharmaceuticals, Inc.: Corporate Governance
Table 22: Progenics Pharmaceuticals, Inc.: Financial Performance
Table 23: Progenics Pharmaceuticals, Inc.: Market Developments
Table 24: Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 25: Progenics Pharmaceuticals, Inc.: Research & Development
Table 26: Progenics Pharmaceuticals, Inc.: Strategy and Operations

★海外企業調査レポート[Progenics Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Belize Electricity Ltd：企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • RadNet Inc (RDNT)：医療機器：M&Aディール及び事業提携情報
    Summary RadNet Inc (RadNet) is a radiology company which specializes in diagnostic imaging services. The company offers freestanding, fixed-site diagnostic imaging services including imaging procedures magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nu …
  • PT Es Teler 77：企業の戦略・SWOT・財務情報
    PT Es Teler 77 - Strategy, SWOT and Corporate Finance Report Summary PT Es Teler 77 - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kaleido Biosciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Kaleido Biosciences Inc (Kaleido Biosciences) is a developer of human microbiomes for the treatment of infectious, rare genetic, inflammatory, oncology and metabolic diseases. The company’s human microbiome is a metabolic engine which is developed from healthy and diseased humans using vario …
  • Acadia Pharmaceuticals Inc (ACAD)-製薬・医療分野：企業M&A・提携分析
    Summary Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company’s lead product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. Acadia also de …
  • Nordson Corporation：企業のM&A・事業提携・投資動向
    Nordson Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordson Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Campofrio Food Group, S.A.：戦略・SWOT・企業財務分析
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Midea Group Co Ltd：企業の戦略・SWOT・財務情報
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fugro NV (FUR)：企業の財務・戦略的SWOT分析
    Fugro NV (FUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Bioorganic Research and Services SA (BNT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • Edenred SA (EDEN)：企業の財務・戦略的SWOT分析
    Edenred SA (EDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Illovo Sugar Africa Pty Ltd：企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • TeneoBio Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary TeneoBio Inc (TeneoBio), formerly OMT Therapeutics Inc is a biotechnology company. The company develops biologics, human heavy chain antibodies as therapeutics that targets the cancer, autoimmunity, and infectious diseases. Its pre-clinical pipeline portfolio includes antibodies such as mult …
  • Nationwide Financial Services, Inc.：企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Molecular Partners AG (MOLN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • El Puerto de Liverpool SAB de CV：企業の戦略・SWOT・財務情報
    El Puerto de Liverpool SAB de CV - Strategy, SWOT and Corporate Finance Report Summary El Puerto de Liverpool SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Brink’s Company：企業の戦略・SWOT・財務情報
    The Brink's Company - Strategy, SWOT and Corporate Finance Report Summary The Brink's Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • General Dynamics Corporation：戦略・SWOT・企業財務分析
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Guyana Goldfields Inc：企業の戦略・SWOT・財務情報
    Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report Summary Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EverPower Wind Holdings Inc：電力：M&Aディール及び事業提携情報
    Summary EverPower Wind Holdings Inc (Everpower), a subsidiary of Terra Firma Capital Partners Limited is a renewable energy company that owns, operates and develops utility scale wind energy projects. The company’s operating projects comprise big sky wind farm, highland wind farm, howard wind projec …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆